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Abstract
Purpose: Compare the precision of doxycycline quantification in tear fluid collected with either Schirmer
strips or polyvinyl acetal (PVA) sponges following oral drug administration.
Methods: Three dogs and 3 cats were administered doxycycline orally at a dose of 4.2–5 mg/kg every 12 h for
6 consecutive days. At day 5 and 6, blood and tear fluid were sampled to capture doxycycline trough and
maximal concentrations. Tear fluid was collected 3 times (spaced 10 min apart) at each session with the
absorbent material placed in the lower conjunctival fornix until the 20-mm mark was reached (Schirmer strip,
one eye) or for 1 min (PVA sponge, other eye). Tear extraction was performed with either centrifugation or
elution in methanol. Doxycycline concentrations were measured with liquid chromatography–mass
spectrometry. Low (100 ng/mL) and high (1,000 ng/mL) tear concentrations measured in vivo were spiked
into each absorbent material in vitro to evaluate percentage drug recovery.
Results: After oral administration of doxycycline, the drug reached the tear compartment at concentrations of
45.1–900.7 ng/mL in cats and 45.4–632.0 ng/mL in dogs, representing a tear-to-serum ratio of 12% and 16%,
respectively. Doxycycline tear concentrations were significantly more precise when tear collection was
performed with Schirmer strips rather than PVA sponges (P = 0.007), but were not correlated with tear flow
rate. In vitro doxycycline recovery was poor to moderate (<75%).
Conclusions: Schirmer strips represent a good option for lacrimal doxycycline quantification, although the
collection and subsequent extraction have to be optimized to improve drug recovery.
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Abstract
Purpose: Compare the precision of doxycycline quantification in tear fluid collected with either Schirmer strips
or polyvinyl acetal (PVA) sponges following oral drug administration.
Methods: Three dogs and 3 cats were administered doxycycline orally at a dose of 4.2–5mg/kg every 12h for 6
consecutive days. At day 5 and 6, blood and tear fluid were sampled to capture doxycycline trough and maximal
concentrations. Tear fluidwas collected 3 times (spaced 10min apart) at each sessionwith the absorbentmaterial placed
in the lower conjunctival fornix until the 20-mmmark was reached (Schirmer strip, one eye) or for 1min (PVA sponge,
other eye). Tear extractionwas performedwith either centrifugation or elution inmethanol. Doxycycline concentrations
were measured with liquid chromatography–mass spectrometry. Low (100ng/mL) and high (1,000ng/mL) tear con-
centrations measured in vivo were spiked into each absorbent material in vitro to evaluate percentage drug recovery.
Results: After oral administration of doxycycline, the drug reached the tear compartment at concentrations of
45.1–900.7 ng/mL in cats and 45.4–632.0 ng/mL in dogs, representing a tear-to-serum ratio of 12% and 16%,
respectively. Doxycycline tear concentrations were significantly more precise when tear collection was per-
formed with Schirmer strips rather than PVA sponges (P = 0.007), but were not correlated with tear flow rate.
In vitro doxycycline recovery was poor to moderate (<75%).
Conclusions: Schirmer strips represent a good option for lacrimal doxycycline quantification, although the
collection and subsequent extraction have to be optimized to improve drug recovery.
Keywords: pharmacokinetics, doxycycline, oral administration, tear film, canine, feline
Introduction
Systemically administered medications are used tomanage a variety of ocular surface diseases across species,
for instance oral cetirizine for allergic conjunctivitis in hu-
mans,1 famciclovir for herpetic keratitis in cats,2 and doxy-
cycline for keratomalacia in horses,3 among others. Although
promising, the prerequisite for such therapies is a deep un-
derstanding of the drug pharmacokinetics–pharmacodynamics
at the ocular surface,4 a process that first requires accurate
quantification of the drug levels in the tear fluid. Indeed, un-
der- or overestimating tear concentrations could cause a drug
to be given at an inappropriate dose and/or frequency, thereby
affecting its efficacy, increasing the risk for drug toxicity, or
development of acquired resistance (for anti-infective drugs).5,6
However, accurate quantification of drug in tears is compli-
cated by the lack of standardized method to collect and analyze
this biological fluid.7–10 This is exemplified by doxycycline, a
broad-spectrum antibiotic that has been shown to reach the
tear compartment in various species: After oral administration,
doxycycline tear concentrations were relatively high in horses
(1,810–9,830ng/mL),11 lower in cats (100–110 ng/mL),12much
lower in dogs (0.04–5.73 ng/mL),13 and nonexistent in hu-
mans.14 The subtle species differences in plasma protein
binding of doxycycline15 cannot solely explain the large dis-
crepancies in the observed tear concentrations; rather, it is
likely that the concentrations obtained have been skewed by
an unrecognized impact from the tear collection process, as is
the case for tear protein content16 and other analytes like glu-
cose,17 and warrants further investigation.
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Direct tear collection with capillary tubes, although com-
monly used in clinical research because the sample obtained
is readily available for analysis,8 presents several drawbacks
that limit its use for drug quantification. In particular, the
volume of tear fluid retrieved is generally low, thus rendering
some samples insufficient for analysis1 unless previous stim-
ulation or topical instillation of saline is performed.18 In ad-
dition, the drug recovery and the accuracy of analysis are
lower than other methods, as shown by Small et al. who noted
that capillary-collected samples underestimated ofloxacin
concentrations in rabbit tears and resulted in greater variability
when compared with Schirmer strips and surgical sponges.19
Indirect tear collection with Schirmer strips and ophthalmic
sponges have been successfully used to quantify lacrimal drug
levels in several species.2,13,19,20 These collection methods are
easy to use, safe, and provide quantities of tear fluid adequate
for most bioanalytical procedures.7,21,22 However, Schirmer
strips and ophthalmic sponges can also cause reflex tearing due
to ocular irritation and therefore affect the detection of the
investigated tear component (eg, drug concentration).21,22
Standardization of the collection methods and controlling tear
flow rate may hinder these physiological changes and improve
the repeatability of the analysis.
The purpose of our study is to compare the repeatability (ie,
precision) of drug quantification on the ocular surface from
tears collected with Schirmer strips or ophthalmic sponges.
We also aim to investigate the impact of the method used to
extract the tears from the absorbent materials, that is, centri-
fugation or elution with a solvent. Doxycycline was selected
as the test drug because it has been shown to reach the tear
compartment in several species,11–13 it has broad-spectrum
antimicrobial activity, and multiple beneficial properties such
as inhibition of matrix metalloproteinases, anti-inflammation,
immunomodulation, and antiangiogenesis.23
Methods
In vivo evaluation: determination
of serum and tear levels
Animals. Three dogs and 3 cats were enrolled in the
study; all confirmed to be ophthalmoscopically healthy
by slit-lamp examination, indirect funduscopy, tonometry,
Schirmer tear test, and fluorescein staining. Dogs comprised
of 1 neutered male Chihuahua, 1 spayed female Great Pyre-
nees, and 1 spayed female Greyhound, with a mean– standard
deviation (SD) (range) age of 5.7–3.5 years (2–9 years) and
body weight of 19.3–13.0 kg (6–32kg). Cats were all Do-
mestic Shorthair breed, comprised of 2 neutered male and 1
spayed female, with a mean–SD (range) age of 3.7–2.3 years
(1–5 years) and body weight of 5.8–1.4 kg (5–7.5 kg). An
informed consent was obtained from all owners. The study was
approved by the Institutional Animal Care and Use Committee
of Iowa State University, and adhered to the Association for
Research in Vision and Ophthalmology (ARVO) statement for
the Use of Animals in Ophthalmic and Vision Research.
Drug administration and sample collection. Doxycycline
hyclate was administered orally at a dose of 4.2–5mg/kg
every 12 h for 6 consecutive days. On both the fifth and sixth
day of drug administration, all subjects had blood and tear
fluid sampled to capture doxycycline trough concentration
(Ctrough; before morning drug administration) and maximal
concentration (Cmax; 3 h after morning drug administration),
as described in Fig. 1. The duration of drug adminis-
tration preceding the first sample collection was selected to
ensure steady-state doxycycline plasma concentrations were
reached, as the plasma half-life was reported to be 10.36 h in
dogs24 and 4.24 h in cats.12
Blood was collected once from each subject at each session
(Ctrough and Cmax at day 5 and 6): the 2–3mL blood sample
retrieved by peripheral venipuncture was placed in a plain red
top tube (containing no anticoagulant), centrifuged at 1,240 g
for 10min, and the extracted serum was stored at -80C until
analysis.
Tear fluid was collected 3 times from each subject at each
session (Ctrough and Cmax at day 5 and 6), allowing 10min
between successive sampling in the same eye to permit return
to basal tearing status.22 For each subject, the right and left
eyes were randomized (Excel 2016; Microsoft, Redmond,
WA) to receive either Schirmer strips (Eye Care Product
Manufacturing, LLC, Tucson, AZ) or polyvinyl acetal (PVA)
sponges (Ultracell Eye Wick; Beaver-Visitec International,
Inc., Waltham, MA), and this selection was kept consistent
over the several sessions. Collection with Schirmer strips was
performed by placing the filter paper in the lower conjunctival
fornix until the strip was wet at the 20-mm mark. Collection
with PVA sponges was performed as previously described22—
briefly, a 4· 10mm strip of PVA sponge was inserted into the
lower conjunctival fornix using a disposable plastic tweezer
(Evident Inc., Union Hall, VA), and was left in place for 60 s.
Once soaked with tears, extraction of tear fluid from these
absorbent materials was performed using 1 of 2 methods:
(1) Centrifugation: The wetted Schirmer strips and PVA
sponges were placed in separate 0.2-mL Eppendorf
tubes that were previously punctured at their bottom
with an 18-gauge needle. Tears were then eluted
through the drainage hole into 1.5-mL Eppendorf
tubes by centrifugation for 1min at 3,884 g (VWR
Mini Centrifuge; VWR International, Radnor, PA).
(2) Methanol elution: The wetted Schirmer strips and PVA
spongeswere placed in separate1.5-mLEppendorf tubes.
Methanol (HPLC grade; Fisher Scientific, Raleigh, NC)
was then added to each tube to immerse the entire ab-
sorbent material (1.5mL for Schirmer strips, 1mL for
PVA sponges).
During each time point, 2 of the 3 tear samples collected
from each eye were processed using the same extraction
method (centrifugation on day 5, methanol elution on day 6;
Fig. 1) so that intrasession variability could be assessed (see
‘‘Data Analysis’’ section).
Assuming tear fluid density equaled 1 g/mL,25 tear volume
absorbed was calculated as the difference of the post- and
precollection weight of the tube containing the Schirmer strip
or PVA sponge (before centrifugation or methanol elution).
Weights were determined to the nearest 0.001 g (Gemini-20;
American Weight Scales, Inc., Norcross, GA). Samples were
then placed in a -80C freezer until analysis.
In vitro evaluation: determination of doxycycline
recovery from absorbent materials
Doxycycline hyclate (Sigma-Aldrich ‡98% HPLC; Sigma-
Aldrich, St Louis, MO) was prepared as solutions of 100 and
1,000ng/mL (representative of low and high tear concentrations
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obtained in the present in vivo experiment) in a buffer made of
50% acetonitrile (HPLC grade; Fisher Scientific, Raleigh, NC),
50% water (HPLC grade; Fisher Scientific, Raleigh, NC), and
0.1% formic acid. Twenty Schirmer strips (wet until the 20-mm
mark was reached) and 20 PVA sponges (spiked with 25mL,
representative of the median volume absorbed by these sponges
in the present in vivo experiment) were used for each doxy-
cycline concentration, 10 of which underwent extraction with
centrifugation while the remaining 10 underwent elution with
methanol, following the same protocol as the in vivo experi-
ment. Samples were then stored at -80C until analysis.
Analytical methods
Sample preparation. Serum and tear samples were
thawed and vortexed gently for 1min (Vortexer 120V;
Fisher Scientific, Hampton, NH). Tear samples obtained by
methanol elution were centrifuged for 6min at 10,000 g
(Labnet International, Edison, NJ), and the supernatants
(0.5mL for PVA samples and 1.0mL for Schirmer samples)
were transferred to LC-MS vials. The samples were dried
with a nitrogen evaporator for 20min, then resuspended in
200 mL of buffer (1:1 acetonitrile:water with 0.1% formic
acid). For tears obtained by centrifugation and for serum
samples, 7–10 and 100 mL of each sample type, respectively,
were transferred to 1.5-mL microcentrifuge tubes and mixed
with 200 or 900 mL of buffer (1:1 acetonitrile:water with
0.1% formic acid), respectively. These samples were then
vortexed for 30 s, left on ice for 10min, and vortexed for
another 30 s before being sonicated in an ice water bath for
10min. Following centrifugation for 7min at 13,000 g, the
supernatant from each sample was transferred to a 0.2 mL
spin filter and centrifuged again for 7min at 13,000 g.
Standard solutions. The following concentrations of
doxycycline hyclate were prepared in a buffer of 1:1 ace-
tonitrile:water with 0.1% formic acid: 1.0, 5.0, 10, 20, 50,
100, 625, 1,000, 1,250, 2,500, and 5,000 ng/mL. Tear cali-
bration curve was made by analyzing doxycycline solutions
of 1, 5, 10, 20, 50, and 100 ng/mL that were each mixed with
10 mL of blank canine and feline tears. Serum calibration
curve was made by analyzing doxycycline solutions of 625,
1,250, 2,500, and 5,000 ng/mL that were each mixed with
30 mL of blank canine and feline serum. A linear correlation
was observed within the range of concentrations considered
for tears (R2 = 0.989) and for serum (R2 = 0.996).
Liquid chromatography/mass spectrometry. An Agilent
6540 Ultra High-Definition Accurate-Mass Q-TOF liquid
chromatography/mass spectrometry (LC/MS) system was
used for sample analysis (Agilent Technologies, San Jose,
CA). LC separations were performed with an Agilent
Technologies’ 1290 Infinity Binary Pump UHPLC instru-
ment equipped with an Agilent Technologies’ Eclipse C18
1.8 mm 2.1mm · 50mm analytical column that was coupled
to an Agilent Technologies’ 6540 UHD Accurate-Mass Q-
TOF mass spectrometer. A volume of 15mL of each sample
was injected into the device, with an initial buffer condition
of 100% water progressing to 100% acetonitrile with 0.1%
formic acid over the 10-min run period. Chromatography
FIG. 1. Diagram of the study design used to assess 3 healthy dogs and 3 healthy cats who were administered oral
doxycycline (4.2–5.0mg/kg every 12 h for 6 days). At both day 5 and 6, serum and tear samples were collected to capture
trough (Ctrough) and maximal (Cmax) concentrations. Tears were collected 3 times at each session, separated 10min apart,
and fluid was extracted from the absorbent material with either centrifugation or methanol elution.
454 SEBBAG ET AL.
was carried out at 40C with a flow rate of 0.6mL/min.
Doxycycline was detected as [M+H]+ ions using electro-
spray ionization in positive mode, while operating in high-
resolution (4Gz) mode with a scan range from m/z 100 to
m/z 1,700. Doxycycline [M+H]+ ions were plotted as an
extracted ion chromatogram using a 10 ppm extraction
window centered around m/z 445.16, and the observed re-
tention time for doxycycline was 3min.
Analyses of blank tear fluid spiked with 2 doxycycline
standard solution (100 and 1,000 ng/mL) were performed to
serve as control for the in vitro study. For the in vivo ex-
periments, the concentrations of doxycycline in the tear fluid
and serum were estimated in ng/mL on the basis of peak area
from the tears and serum calibration curves, respectively,
taking into account the various dilutions performed during the
sample preparation.
Data analysis
Normality of the data was assessed with the Shapiro–Wilk
test. For normally distributed data, parametric tests were used
for analysis and results were expressed as mean–SD. Non-
normally distributed data were analyzed with nonparametric
statistics and results were expressed as median and 95% range
(2.5th percentile–97.5th percentile). Comparison of serum
doxycycline levels was performed with the unpaired t-test (dogs
vs. cats) and the Mann–Whitney rank test (Ctrough vs. Cmax).
Comparison of tear doxycycline levels between dogs versus
cats, and between Ctrough versus Cmax were performed with
the Kruskal–Wallis test followed by Dunn’s pairwise compar-
ison, taking into account the following 4 collection/extraction
methods: (1) Schirmer strip/centrifugation, (2) Schirmer strip/
methanol elution, (3) PVA sponge/centrifugation, and (4) PVA
sponge/methanol elution. When no statistical differences were
noted, data from both species as well as both trough and
maximal concentrations were combined for future analysis,
described thereafter as ‘‘serum doxycycline concentration’’ and
‘‘tear doxycycline concentration.’’ Differences in the doxycy-
cline concentrations obtained in vivo and in vitro with each of
the aforementioned group were evaluated with the Kruskal–
Wallis test followed by Dunn’s pairwise comparison.
Correlations. Spearman’s rank correlation tests were
used to assess correlations between the following parame-
ters: (1) tear doxycycline concentration versus tear flow rate
(defined as the volume absorbed by the absorbent material
per minute), and (2) serum doxycycline concentration versus
tear doxycycline concentration obtained by each of the 4
collection/extraction methods.
Intrasession variability. The variability of the tear doxy-
cycline concentrations obtained by the same method during the
same session was evaluated with the coefficient of variation
(CV), expressed in %, defined as the ratio of the SD by the
mean values of doxycycline concentrations. Differences in
CV% between Schirmer strips and PVA sponges were evalu-
ated with the Mann–Whitney test, whereas differences in CV%
among the 4 collection/extraction methods were assessed with
the Kruskal–Wallis test.
Results
Data were non-normally distributed (P < 0.05), except for
serum doxycycline concentrations (P‡ 0.354) and tear vol-
ume absorbed (P ‡ 0.118).
In vivo evaluation: determination
of serum and tear levels
Serum concentrations of doxycycline were not statisti-
cally different between trough and maximal measurements
in both species (P ‡ 0.650). The drug could be quantified in
all sera samples collected: mean – SD (range) concentrations
were 1301.8– 602.0 ng/mL (469.1–2356.5 ng/mL) in dogs and
1531.6– 804.6 ng/mL (329.5–3208.4 ng/mL) in cats, a differ-
ence that was not statistically significant (P= 0.437). Mean–
SD (range, CV%) tear volume absorbed was 17.6– 2.3mL
(13–22mL, 13%) for Schirmer strips and 27.6– 17.7mL (3–
70mL; 64%) for PVA sponges. Tear concentrations of doxy-
cycline were below the limit of quantification (<1 ng/mL) in
29/144 samples collected, a finding mostly noted in cats and
methanol-eluted tears (Appendix 1). Median (95% range)
tear levels were 182.0 ng/mL (45.4–632.0 ng/mL) in dogs and
172.0 ng/mL (45.1–900.7 ng/mL) in cats, a difference that was
not statistically significant (P= 0.865).
Tear concentrations were not statistically different between
trough and maximal concentrations in both species and in both
collection methods (P=1.000; Table 1). In tear samples col-
lected with Schirmer strips, centrifugation extraction achieved
greater doxycycline levels than methanol elution for both
Ctrough (P=0.002) and Cmax (P<0.001; Table 1). In tear sam-
ples collected with PVA sponges, doxycycline levels were
greater with centrifugation extraction for Cmax (P=0.025), but
not Ctrough (P=0.121; Table 1).
Table 1. Median –Standard Error (95% Range) Trough and Maximal Concentrations
of Doxycycline in Tear Fluid of 3 Healthy Dogs and 3 Healthy Cats Receiving 4.2–5mg/kg
Doxycycline Per orally for 6 Consecutive Days
In vivo
Schirmer strips PVA spongesDoxycycline
concentration Centrifugation Methanol elution Centrifugation Methanol elution
Ctrough
(ng/mL)
279.6 – 24.2 (143.3–458.2)* 63 – 57.9 (44.8–543.7) 176– 59.2 (119.3–831.8) 65.4 – 12.7 (33.7–138.8)
Cmax
(ng/mL)
441.1 – 79.2 (308.8–1388.1)* 87 – 53.9 (53.9–156.6) 278– 26.1 (186.4–552.5)* 96.8 – 57.2 (38.7–650.7)
Tears were collected in vivo with either Schirmer strips or PVA sponges, and fluid was subsequently extracted by centrifugation or methanol
elution. For the same absorbent material, significant differences between centrifugation versus methanol are noted with an asterisk (*).
PVA, polyvinyl acetal.
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Correlations. Concentrations of doxycycline were not
correlated between serum and tear fluid for any collection/
extraction method (P‡ 0.221), except for Schirmer strips
followed by centrifugation (r= 0.424, P= 0.013). Furthermore,
no significant correlation was noted between tear flow rate
and tear doxycycline concentrations for either Schirmer strips
(P= 0.87; Fig. 2A) or PVA sponges (P= 0.640; Fig. 2B).
Intrasession variability. Median – standard error (95%
range) CV% of tear samples collected with Schirmer
strips (9.7%– 3.4%, 1.1%–46.6%) was significantly lower
(P = 0.007) compared with samples collected with PVA
sponges (21.4%–7.6%; 6.7%–93.0%; Fig. 3). When consid-
ering the subsequent extraction method, CV% was confirmed
to be lower for Schirmer strips [centrifugation: 8.5%–5.0%
(0.8%–47.6%); methanol elution: 14.3%–3.8% (2.8%–25.3%)]
compared with PVA sponges [centrifugation: 21.4%–8.7%
(8.5%–92.5%); methanol elution: 34.2%–17.6% (8.0%–
76.3%)], although differences among these 4 groups were not
statistically significant (P‡0.054).
In vitro evaluation: determination of doxycycline
recovery from absorbent materials
Results of the in vitro experiment are summarized in
Table 2. There were no significant differences (P ‡ 0.210) in
the recovery of doxycycline between Schirmer strips and
PVA sponges for either extraction methods (centrifugation
or methanol-elution) or doxycycline solutions (100 and
1,000 ng/mL). Median CV% of doxycycline quantitation
was overall similar between Schirmer strips and PVA
sponges for the 100 ng/mL solution (35.7% and 32.1%, re-
spectively) and the 1,000 ng/mL solution (19.4% and 27.2%,
respectively). The recovery of doxycycline from the absor-
bent materials was often greater with 100 ng/mL versus
1,000 ng/mL of doxycycline solution, and this difference
was statistically significant for centrifuged PVA sponges
(P < 0.001).
Discussion
Precise quantification of tear fluid concentrations following
systemic therapy is critical for many reasons. First, systemic
medications can be used to treat various ocular surface dis-
eases, and accurate tear concentrations are necessary to de-
termine dose and frequency of administration. Second,
lacrimal fluids can be used to correlate drug concentrations
with ocular adverse effects of systemic drugs, such as con-
junctivitis from nonsteroidal anti-inflammatories26 or drug-
induced corneal epithelial changes.27 Third, tears have been
shown to be the best practical indicator of the unbound frac-
tion of various drugs, such as phenobarbital28 and theophyl-
line,29 and therefore represent an excellent alternative to
invasive blood or cerebrospinal fluid collection.
After oral administration, doxycycline reached the tear
compartment at concentrations of 45.1–900.7 ng/mL in cats
and 45.4–632.0 ng/mL in dogs. In fact, these values may
represent underestimations of the ‘‘true’’ concentrations, as
our preliminary in vitro data showed an incomplete recovery
of doxycycline from the absorbent materials with the ex-
traction protocols used in the present study. Furthermore,
the analytical method used in the present study did not use
an isotopically labeled internal standard of doxycycline, a
limitation that likely affected the accuracy of the measure-
ments from the LC/MS assay.30 Thus, the range of tear
concentrations in dogs and cats needs to be substantiated by
additional studies with a larger population size. Regardless
of these limitations, these measured concentrations are up to
9-fold and 1,000-fold greater than those previously reported
in cats and dogs, respectively.12,13 Because serum doxycy-
cline concentrations were overall consistent with data pub-
lished in previous canine and feline studies using similar
doses of oral doxycycline,12,31 the large discrepancy in
concentrations measured in the lacrimal fluid could be im-
puted, at least partially, to the different methodologies used
for tear collection and extraction.
The average tear-to-serum ratio of doxycycline concen-
trationswas 16% in dogs and 12% in cats, somewhat similar to
penciclovir (20%)2 but lower than pradofloxacin in cats (36–
1,818%).12 These differences in lacrimal distribution might
be due to physicochemical properties inherent to each drug
such as lipophilicity, protein binding, molecular mass, and
pKa.
10 Of note, the tear-to-serum ratio was greater in tear
samples collected with Schirmer strips and extracted with
centrifugation (27%) compared with other methods (5%–
16%). This, combined with the steady volumes of tear fluid
FIG. 2. Spearman’s rank correlation test for tear doxycycline concentrations and tear flow rate. No significant associations
were found for either Schirmer strips (A) or PVA sponges (B). PVA, polyvinyl acetal.
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obtained with Schirmer strips at each collection time (20-mm
mark wetting), may partly explain the positive correlation
noted for this method between serum and tear concentrations
of doxycycline. Furthermore, it is important to note that our
work and the aforementioned studies were performed in
healthy eyes. Breakdown of the blood–ocular barrier, as seen
with conjunctivitis-induced vessel fragility, may increase the
tear-to-serum ratio by allowing direct passage of drug from
the serum to the tear fluid.1 In humans with allergic con-
junctivitis, oral administration of cetirizine achieved tear
concentrations nearly identical to serum concentrations after
60min, indicating that a pharmacokinetic equilibriumhas been
reached relatively quickly between the 2 compartments.1 In
humans with trachomatous conjunctivitis, administration of
minocycline achieved sustained tear concentrations for 48 h
following a single oral dose.32 Future studies should investigate
the impact of conjunctivitis on lacrimal drug levels.
In the present study, doxycycline tear concentrations were
not correlated with tear flow rate in dogs and cats. The stable
concentration profile of tear doxycycline over a wide range
of tear flow rates suggest that the drug secretion into the tear
compartment increases with the rate of lacrimal stimula-
tion. This is similar to ‘‘regulated’’ lacrimal proteins, such as
lysozyme and lactoferrin,33 but is in contrast to ‘‘constitu-
tive’’ and ‘‘serum-derived’’ tear compounds, such as IgA and
IgG, respectively, for which the tear concentrations decrease
with increasing stimulus due to dilution effect.33 Ad-
ditionally, it is plausible that doxycycline accumulates in the
lacrimal gland after days of oral administration, similar to
cyclosporine A,18 thus explaining the pattern of concentra-
tions observed in the present study.
Importantly, our study found that doxycycline tear concen-
trations were more repeatable when tear collection was per-
formed with Schirmer strips rather than PVA sponges. Schirmer
strips are thinner than PVA sponges (0.22mm vs. 1mm) and
this may help extract the drug from the absorbent material in a
more consistent way, thus providing a possible explanation for
the lower variability of doxycycline in tear samples. Further,
differences in water affinity between Schirmer strips and PVA
sponges,22 combined with different physical properties, such as
porosity, pore size, and permeability,34 may explain the (non-
significant) discrepancy noted herein in the quantity of doxy-
cycline extracted from each collection device.
Of note, Schirmer strips allow for standardization of the
tear volume absorbed at each session by controlling the mm-
mark of wetness (intersession differences in VA £4mL),
whereas PVA sponges yield more variable tear volumes
despite controlling for the collection duration (intersession
differences in VA £37 mL). This variability is likely due to
reflex tearing, and although it did not impact doxycycline
concentrations in the present study (no correlation between
tear flow rate and doxycycline concentrations), it may par-
ticipate in data variability when tear sampling is not per-
formed at steady-state plasma levels. Indeed, a recent study
on minocycline collected tear fluid in ponies with ophthal-
mic sponges, and the authors noted large discrepancies in
lacrimal drug concentrations between one subject to an-
other.35 Therefore, we believe that Schirmer strips represent
a better option for lacrimal doxycycline quantification, of-
fering a good compromise between collection of a sufficient
amount of tears (for allowing bioanalytical quantitation) and
patient tolerance (for the respect of lacrimal physiology).
However, this finding should be verified for other drugs as
results may be affected by diverse compound characteristics
(eg, size, lipophilicity, and protein binding). Also, given the
several in vivo samples that were below the quantification
limit and our preliminary in vitro data showing suboptimal
drug recovery, tear collection with Schirmer strips has to be
optimized for it to become the standard collection method
for pharmacokinetic studies. Indeed, postcollection proces-
sing of Schirmer strips has been shown to impact the lac-
rimal protein content,36 and the same is likely to be true for
drug levels. The following are a few suggestions that can be
investigated in future studies:
FIG. 3. Bar chart depicting median + standard error of the
coefficient of variation in doxycycline concentrations of
tears collected in vivo with Schirmer strips or PVA sponges.
A significant difference was noted between both collection
methods (P= 0.007). PVA, polyvinyl acetal.
Table 2. Median – Standard Error (95% Range) Percentage Recovery of Doxycycline
In Vitro from Schirmer Strips and PVA Sponges Spiked with Either 100 or 1,000ng/mL
Doxycycline Solutions, Then Processed with Either Centrifugation or Methanol Elution
In vitro
Schirmer strips PVA spongesDoxycycline
solution Centrifugation Methanol elution Centrifugation Methanol elution
100 ng/mL 60.7 – 13.2 (32.1–100.8) 52.3 – 3.4 (46.3–64.5) 75.0 – 1.9 (67.4–77.0)* 38.4 – 2.0 (35.2–44.1)
1,000 ng/mL 31.8 – 3.0 (22.6–38.5) 40.2 – 1.0 (39.4–43.4) 24.8 – 1.1 (22.9–27.5) 40.0 – 2.1 (37.1–45.6)
For the same absorbent material and the same extraction method, significant differences between the recovery from 100 ng/mL versus
1,000 ng/mL solutions are noted with an asterisk (*).
PVA, polyvinyl acetal.
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(1) Adjust the volume absorbed by the Schirmer strip to
collect only the basal lacrimal lake (6.2–7.0 mL in
humans,37 unknown in dogs and cats), so that any
dilution effect from reflex tearing is reduced.19 If so,
extraction of the tears with solvent elution would be
preferable, as the amount of fluid recovered by cen-
trifugation of such low volumes is often negligible
(<5 mL; L. Sebbag, unpublished observations).
(2) Improve the extraction of drug by cutting the Schirmer
strip in small pieces,13 allowing sufficient contact time
between the solvent and the Schirmer strip,36 and us-
ing ultrasonic agitation to facilitate diffusion.12,20
(3) Establish the analytical calibration curve by spiking
Schirmer strips with known concentrations of the
drug of interest, and processing these standards the
same way as the biological samples.38 This approach
may help account for the potential adsorptive prop-
erties of the Schirmer strips for a wide range of drug
concentrations.
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Appendix A1. Number of Tear Samples in Dogs and Cats for Which Doxycycline Measurement
Was Below Limit of Quantification, Detailing the Collection Device and Extraction
Method Used as Well as the Associated Volume of Tears Absorbed
Schirmer strips PVA sponges
Centrifugation Methanol elution Centrifugation Methanol elution
Dogs
Number of samples BLQ 0/18 3/18 0/18 4/18
Mean volume absorbed (mL) 18.3 18.9 40.3 19.1
Cats
Number of samples BLQ 2/18 7/18 3/18 9/18
Mean volume absorbed (mL) 16.1 16.6 26.0 18.1
BLQ, below limit of quantification; PVA, polyvinyl acetal.
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